Insider sale notice: Astera Labs (NASDAQ: ALAB) 281,250-share filing
Rhea-AI Filing Summary
Astera Labs filer submitted a Form 144 for the resale of 281,250 shares of Common Stock, including securities acquired as RSUs on 02/15/25. The filing lists J.P. Morgan Securities LLC as broker-dealer.
The filing also discloses prior sales by the same holder: 94,971 shares sold on 02/17/2026 for $11,758,145.75.
Positive
- None.
Negative
- None.
Insights
Form 144 notifies planned resale of 281,250 shares by an RSU recipient.
The filing lists 281,250 shares as the securities to be sold and identifies J.P. Morgan Securities LLC as the broker. It states the shares were acquired as RSUs on 02/15/25, which clarifies the holding origin.
Reported prior activity shows 94,971 shares sold on 02/17/2026 for $11,758,145.75. Subsequent trading will depend on holder actions and brokerage execution; timing and sale method details are not provided in the excerpt.
Notice documents resale intent by an insider/recipient under Rule 144 procedures.
The filing explicitly links the resale to securities "acquired from Issuer as RSUs on 02/15/25," indicating these are restricted-origin shares being offered for resale. The broker is identified as J.P. Morgan Securities LLC.
Because Form 144 is a required notification, this is procedural rather than a corporate action; cash-flow treatment for future sales and any limits or caps are not stated in the provided excerpt.
FAQ
What does Astera Labs' (ALAB) Form 144 disclose about the offering?
How many shares did the reporting holder recently sell under ALAB filings?
Who is the registered seller named in the Form 144 for ALAB?
Are the shares being offered by ALAB subject to any origin note in the filing?